Kantoko raises $3.5M seed to fix Australia's ADHD treatment bottleneck
What's the deal? KantokoDealroom has a profile for this one. Try Dealroom →, an Australian startup simplifying ADHD assessment and treatment, has raised $3.5 million in seed funding. Side Stage VenturesDealroom has a profile for this one. Try Dealroom → led the round, with Andrew Forrest's healthtech firm TenmileDealroom has a profile for this one. Try Dealroom →, Go1 founders Vu TranDealroom has a profile for this one. Try Dealroom → and Andrew BarnesDealroom has a profile for this one. Try Dealroom →, and Tyler Dikman also backing it.
Who's behind it? Founder Zac Altman is a repeat entrepreneur — he sold taxi-hailing app Taxi ProDealroom has a profile for this one. Try Dealroom → to The Catch GroupDealroom has a profile for this one. Try Dealroom → in 2012 and traveltech startup LoungeBuddyDealroom has a profile for this one. Try Dealroom → to American ExpressDealroom has a profile for this one. Try Dealroom →, then spent time as a VP at the finance giant. Kantoko, founded in 2023, is his third venture.
Why now? Altman built the company after his own frustration re-accessing ADHD treatment in Australia. "There was a point during the process that, for lack a better phrasing, I would say I snapped," he said, questioning why treatment cost so much and took so long.
What's the endgame? Kantoko provides assessments for people who suspect they have ADHD and long-term treatment for those already diagnosed, delivered by clinicians via telehealth. It charges $100 a month and aims to cut costs and improve access for rural Australians, who can wait a year or more for treatment.
What's the money for? The funding will expand Kantoko's roster of clinicians and build out its software. Altman bootstrapped the company alongside an early investment from LoungeBuddy co-founder Tyler Dikman before this round.
The signal: The raise lands at the 34th percentile for seed rounds by size — modest, but demand is clear. Australians filling ADHD prescriptions have risen more than 600% since 2017, per UNSWDealroom has a profile for this one. Try Dealroom → data. "Hundreds of thousands of adults wait years for a diagnosis, at real cost to themselves, their families and the economy," said Tenmile managing director Steve Burnell.
Read more: Forbes Australia
Image credit: Generated with Gemini
